Loon Energy Announces Update on Transaction with Optimind Pharma

Toronto, Ontario--(Newsfile Corp. - June 16, 2022) - Loon Energy Corporation (TSXV: LNE) (the "Company") is pleased to announce that it has applied for listing of its common shares on the Canadian Securities Exchange ("CSE") and intends to complete its previously announced reverse takeover transaction (the "Transaction") with Optimind Pharma Inc. in July, 2022. Full details of the Transaction can be found in the Company's news releases on November 30, 2021, December 23, 2021 and April 4, 2022.

In connection with completion of the Transaction, the Company has requested the delisting of its shares from the NEX of the TSX Venture Exchange effective June 24, 2022. Shareholders of Loon approved the delisting of its shares at a shareholders' meeting held on January 4, 2022.

For further information:

Loon Energy Corporation
Harvey McKenzie, Chief Financial Officer
Email: [email protected]
Telephone: 416-400-8003

Not for distribution to U.S. news wire services or for dissemination in the United States.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/128079

You May Also Be Interested In

• Asia's Debut of LEAP East in HKCEC Marks Hong Kong's Largest Inaugural Tech Summit
• Christina Bedal Announces Release of The Shark Effect, A New Framework for Understanding Workplace Instincts
• VEON and JazzWorld Acquire TPL Insurance to Expand Digital Insurance Access Across Pakistan